Cures, jobs, ethics on the line in vote on stem cell research
By Megha Satyanarayana,
Detroit Free Press
| 09. 24. 2008
Opposing sides dig in as vote nears on Proposal 2
Ryan Dinkgrave lived a carefree life in Livonia until he was diagnosed with type I diabetes at age 10. Suddenly everything was ordered and careful.
"It makes you rethink everything you do," he said. "You're young, you're told you need to do shots, you're measuring your blood sugar. You have to count, carefully measure everything you eat."
Dinkgrave, now 25 and of Royal Oak, is among Michigan residents who support Proposal 2, a November ballot initiative allowing Michigan researchers to make embryonic stem cell cultures from excess embryos donated from fertility treatments. Researchers say the cells could unlock the secrets of disease and lead to cures for illnesses such as Alzheimer's and type I diabetes.
Voters will decide this emotionally charged issue on the basis of a 100-word ballot initiative -- one that could not only affect people's health, but also the economy of Michigan for decades to come. Proponents say the measure could spark a life sciences sector and pump billions of dollars into the state's struggling economy.
Opponents insist embryonic stem cell research is unnecessary because alternative types...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
By Emily Mullin, Wired | 03.23.2026
As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks.”
Bay Area-based R3 Bio has been quietly pitching the...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...